290 related articles for article (PubMed ID: 34187751)
1. Serum uric acid variability increases the risk of postoperative chronic kidney disease in patients with renal cell carcinoma after radical nephrectomy.
Li X; Li Z; Wu X; Zhang M; Xu L; Hao X; Li H; Qiao P; Wang W
Urol Oncol; 2021 Aug; 39(8):500.e1-500.e7. PubMed ID: 34187751
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Renal Volume: A Surrogate Measure for Radical Nephrectomy-Induced Chronic Kidney Disease.
Wu FM; Tay MH; Tai BC; Chen Z; Tan L; Goh BY; Raman L; Tiong HY
J Endourol; 2015 Dec; 29(12):1406-11. PubMed ID: 26204258
[TBL] [Abstract][Full Text] [Related]
3. Uric acid levels correlate with baseline renal function and high levels are a potent risk factor for postoperative chronic kidney disease in patients with renal cell carcinoma.
Jeon HG; Choo SH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
J Urol; 2013 Apr; 189(4):1249-54. PubMed ID: 23159461
[TBL] [Abstract][Full Text] [Related]
4. The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study.
Ye M; Hu K; Jin J; Wu D; Hu P; He Q
BMC Nephrol; 2018 Jul; 19(1):190. PubMed ID: 30064367
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid to creatinine ratio is a useful predictor of renal dysfunction among diabetic persons.
Kawamoto R; Ninomiya D; Kikuchi A; Akase T; Kasai Y; Ohtsuka N; Kumagi T
Diabetes Metab Syndr; 2019; 13(3):1851-1856. PubMed ID: 31235105
[TBL] [Abstract][Full Text] [Related]
6. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
[TBL] [Abstract][Full Text] [Related]
7. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis.
Ahn T; Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Hawley CM; Johnson DW; Marco DJT; McStea M; Neale RE; Pascoe EM; Wood ST; Jordan SJ;
J Surg Oncol; 2018 Jun; 117(7):1597-1610. PubMed ID: 29790163
[TBL] [Abstract][Full Text] [Related]
8. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
[TBL] [Abstract][Full Text] [Related]
9. The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
Mason R; Kapoor A; Liu Z; Saarela O; Tanguay S; Jewett M; Finelli A; Lacombe L; Kawakami J; Moore R; Morash C; Black P; Rendon RA
Urol Oncol; 2016 Nov; 34(11):486.e1-486.e7. PubMed ID: 27344410
[TBL] [Abstract][Full Text] [Related]
10. The incidence and risk factors of chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma.
Wang S; Liu Z; Zhang D; Xiang F; Zheng W
BMC Cancer; 2022 Nov; 22(1):1138. PubMed ID: 36335288
[TBL] [Abstract][Full Text] [Related]
11. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
[TBL] [Abstract][Full Text] [Related]
12. Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery.
Wu J; Suk-Ouichai C; Dong W; Antonio EC; Derweesh IH; Lane BR; Demirjian S; Li J; Campbell SC
BJU Int; 2018 Jan; 121(1):93-100. PubMed ID: 28834125
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the development of chronic renal insufficiency after renal surgery: a multicenter study.
Choi YS; Park YH; Kim YJ; Kang SH; Byun SS; Hong SH
Int Urol Nephrol; 2014 Apr; 46(4):681-6. PubMed ID: 24072453
[TBL] [Abstract][Full Text] [Related]
14. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
15. Comparison of postoperative estimated glomerular filtration rate between kidney donors and radical nephrectomy patients, and risk factors for postoperative chronic kidney disease.
Lee SH; Kim DS; Cho S; Kim SJ; Kang SH; Park J; Park SY; Chang SG; Jeon SH
Int J Urol; 2015 Jul; 22(7):674-8. PubMed ID: 26012527
[TBL] [Abstract][Full Text] [Related]
16. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma.
Kim YW; Kim WT; Yun SJ; Lee SC; Kim WJ; Ha YS; Park YH; Kang SH; Hong SH; Kwon TG; Byun SS; Kwak C; Kim YJ
Ann Surg Oncol; 2015 Nov; 22(12):4098-103. PubMed ID: 25851339
[TBL] [Abstract][Full Text] [Related]
18. Impact of warm ischaemia time on postoperative renal function after partial nephrectomy for clinical T1 renal cell carcinoma: a propensity score-matched study.
Lee H; Song BD; Byun SS; Lee SE; Hong SK
BJU Int; 2018 Jan; 121(1):46-52. PubMed ID: 28749082
[TBL] [Abstract][Full Text] [Related]
19. Histologic Abnormalities in Non-neoplastic Renal Parenchyma and the Risk of Chronic Kidney Disease Following Radical Nephrectomy.
Brandina R; Moreira Leite KR; Gregório EP; Fernandes KBP; Srougi M
Urology; 2017 Feb; 100():158-162. PubMed ID: 27725235
[TBL] [Abstract][Full Text] [Related]
20. Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma.
Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Marco DJT; Neale RE; Wood ST; Jordan SJ;
Clin Genitourin Cancer; 2019 Jun; 17(3):e581-e591. PubMed ID: 30975606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
